Klimek, Ludger; Buhl, Roland; Deitmer, Thomas et al.
Recommendations for use of topical inhalant budesonide in COVID-19 A position paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO). German versionHNO. 2021
Klimek, Ludger; Buhl, Roland; Deitmer, Thomas et al.
Recommendations for use of topical inhalant budesonide in COVID-19 A position paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO). German versionHNO. Bd. 69. H. 8. 2021 S. 611-614
Boulos, Joelle C.; Saeed, Mohamed E. M.; Chatterjee, Manik et al.
Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma CellsPHARMACEUTICALS. Bd. 14. H. 11. 2021
Holig, Kristina; Schmidt, Helmuth; Hutter, Gero et al.
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial (vol 56, pg 635, 2021)BONE MARROW TRANSPLANTATION. Bd. 57. H. 1. 2021 S. 143-143
Schott, Kerstin; Majer, Catharina; Bulashevska, Alla et al.
SAMHD1 in cancer: curse or cure?JOURNAL OF MOLECULAR MEDICINE-JMM. Bd. 100. H. 3. 2021 S. 351-372
Awwad, Mohamed H. S.; Mahmoud, Abdelrahman; Bruns, Heiko et al.
Selective elimination of immunosuppressive T cells in patients with multiple myelomaLEUKEMIA. Bd. 35. H. 9. 2021 S. 2602-2615
Mai, Sandra Stephanie; Vogt, Annika Renate; Schmidtmann, Irene et al.
Sequential use of the Demoralization Scale in palliative care: feasibility, strain, and personal benefits of participation for patients at the end of lifeSUPPORTIVE CARE IN CANCER. Bd. 29. H. 2. 2021 S. 965-973
Wagner-Drouet, Eva; Teschner, Daniel; Wolschke, Christine et al.
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantationHAEMATOLOGICA. Bd. 106. H. 2. 2021 S. 363-374
Mytilineos, Daphne; Tsamadou, Chrysanthi; Neuchel, Christine et al.
The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter AnalysisFRONTIERS IN IMMUNOLOGY. Bd. 11. 2021
Witzens-Harig, Mathias; Viardot, Andreas; Keller, Ulrich et al.
The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM TrialHEMASPHERE. Bd. 5. H. 10. 2021